Whitehawk Therapeutics, Inc. (WHWK) Total Assets by Year
Whitehawk Therapeutics, Inc. closed fiscal year 2025 with $150.8M in total assets, $14.5M in total liabilities and $136.3M in shareholder equity. This represents an increase of 114.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Whitehawk Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
WHWK Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $150.8M+114.5% | $70.3M-46.9% | $132.4M-28.1% | $184.2M+16.7% | $157.9M+738.8% | $18.8M-52.9% | $39.9M-37.7% | $64.1M+204.9% | $21.0M+777.3% | $2.4M+12835.8% | $19K+252.1% | $5K-40.1% | $9K+8.3% | $8K | N/A |
| Total Liabilities | $14.5M-18.6% | $17.8M-34.5% | $27.2M+5.3% | $25.9M+20.3% | $21.5M-31.2% | $31.3M-36.2% | $49.0M+798.5% | $5.5M+51.9% | $3.6M-95.9% | $88.6M+33.1% | $66.6M+41429.4% | $160K+20.5% | $133K+28.3% | $104K | N/A |
| Total Equity | $136.3M+159.7% | $52.5M-50.1% | $105.2M-33.6% | $158.4M+16.1% | $136.4M+1197.2% | -$12.4M-36.7% | -$9.1M-115.5% | $58.7M+236.5% | $17.4M+120.2% | -$86.2M-29.5% | -$66.6M-42827.2% | -$155K-24.8% | -$124K-30.0% | -$96K-40.1% | -$68K |
WHWK Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $194.0M+7.3% | $127.2M-45.6% | $150.8M+114.5% | $167.0M+94.9% | $180.8M+77.9% | $234.0M+110.7% | $70.3M-46.9% | $85.7M-38.6% | $101.6M-32.8% | $111.1M-34.9% | $132.4M-28.1% | $139.7M-28.0% |
| Total Liabilities | $11.1M+26.4% | $11.1M-9.9% | $14.5M-18.6% | $9.8M-41.5% | $8.8M-61.6% | $12.3M-40.5% | $17.8M-34.5% | $16.8M-21.6% | $22.8M+15.2% | $20.6M-16.4% | $27.2M+5.3% | $21.5M-14.1% |
| Total Equity | $182.9M+6.3% | $116.2M-47.6% | $136.3M+159.7% | $157.2M+128.2% | $172.1M+118.4% | $221.7M+145.1% | $52.5M-50.1% | $68.9M-41.7% | $78.8M-40.0% | $90.5M-38.0% | $105.2M-33.6% | $118.2M-30.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Whitehawk Therapeutics, Inc. financials
Frequently Asked Questions
What was Whitehawk Therapeutics, Inc.'s total assets in fiscal year 2025?
Whitehawk Therapeutics, Inc. closed fiscal year 2025 with $150.8M in total assets, $14.5M in total liabilities and $136.3M in shareholder equity.
How fast is Whitehawk Therapeutics, Inc.'s total assets growing?
Whitehawk Therapeutics, Inc. (WHWK) total assets rose by 114.5% year over year, from $70.3M to $150.8M in fiscal year 2025.
What was Whitehawk Therapeutics, Inc.'s total assets in the most recent quarter?
Whitehawk Therapeutics, Inc. (WHWK) reported $194.0M in total assets in Q2 2026. This represents an increase of 7.3% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Whitehawk Therapeutics, Inc. (WHWK) reported on that line in every period on record.